Turn Therapeutics Exec Zuraiz Chaudhary Buys 2500 Shares at $3.62/Share on 2025-11-17.

lunes, 17 de noviembre de 2025, 10:21 pm ET1 min de lectura
TTRX--

Turn Therapeutics Inc. (TTRX) has recently disclosed that Chaudhary Zuraiz, a member of the company's board of directors, has made a significant investment in the company. On November 17, 2022, Chaudhary Zuraiz purchased 2500 shares of TTRX at a price of $3.62 per share. This acquisition demonstrates the company's strong potential for growth and highlights the confidence that its directors have in its prospects.

Turn Therapeutics Exec Zuraiz Chaudhary Buys 2500 Shares at $3.62/Share on 2025-11-17.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios